Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
22192501000001118 | Rizatriptan 10mg oral lyophilisates sugar free 3 tablet (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
22192601000001119 | Rizatriptan 10mg oral lyophilisates sugar free 3 tablet | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Maxalt Melt 10mg oral lyophilisates (Organon Pharma (UK) Ltd) 3 tablet | Is a | True | Rizatriptan 10mg oral lyophilisates sugar free 3 tablet | Inferred relationship | Existential restriction modifier | |
Maxalt Melt 10mg oral lyophilisates (Mawdsley-Brooks & Company Ltd) 3 tablet | Is a | True | Rizatriptan 10mg oral lyophilisates sugar free 3 tablet | Inferred relationship | Existential restriction modifier | |
Maxalt Melt 10mg oral lyophilisates (PI) (Waymade Ltd) 3 tablet | Is a | True | Rizatriptan 10mg oral lyophilisates sugar free 3 tablet | Inferred relationship | Existential restriction modifier | |
Maxalt Melt 10mg oral lyophilisates (Doncaster Pharmaceuticals Ltd) 3 tablet | Is a | True | Rizatriptan 10mg oral lyophilisates sugar free 3 tablet | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets